<DOC>
	<DOC>NCT02914119</DOC>
	<brief_summary>Aim: To explore - the frequency of use of objective neuromuscular monitoring for assessment of depth of neuromuscular blockade in general anaesthesia - the incidence of residual neuromuscular blockade, and - the timing of reversal of the neuromuscular blockade at the end of anaesthesia. We will collect data from 7 Danish anaesthesia departments, using data from the Anaesthesia Information Management System (AIMS).</brief_summary>
	<brief_title>Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals</brief_title>
	<detailed_description />
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Mivacurium</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<mesh_term>Succinylcholine</mesh_term>
	<mesh_term>Neuromuscular Blocking Agents</mesh_term>
	<criteria>Patients who received general anaesthesia with neuromuscular blockade in one of the 7 hospitals providing data for the study in the last 18 months up until the time of data collection</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Residual nerve blockade</keyword>
	<keyword>Neuromuscular monitoring</keyword>
	<keyword>Residual curarization</keyword>
	<keyword>Neuromuscular blocking agents</keyword>
</DOC>